Respiratory Muscle Assessment in Acute Guillain-Barré-Syndrome
- Conditions
- G61.0Guillain-Barré syndrome
- Registration Number
- DRKS00004236
- Lead Sponsor
- niklinik FreiburgAbt. Pneumologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Acute Guillain-Barré-Syndrome
Exclusion Criteria
pre-existing respiratory muscle disorders
pre-existing neuromuscular disease other Guillain-Barré-Syndrome
severe restrictive chest disease
severe respiratory infectious disease
obstructive lung function impairment (FEV1/FVC<70%)
systemic steroid therapy (daily prednisolone equivalent >10mg)
electronically implanted devices
metal implants in the head/neck region
coagulation disorder (Quick<30%)
pregnancy
severe obstructive sleep apnea
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Objectively assessed respiratory muscle affection of the diaphragm using magnetic phrenic nerve stimulation in patients with Guillain-Barrè Syndrome within the first week of disease onset.
- Secondary Outcome Measures
Name Time Method What is the time course of respiratory muscle affection in acute Guillain-Barré Syndrome?<br>Are there better prognostic markers than vital capacity measurements in acute Guillain-Barrè Syndrome to assess respiratory muscle affection?<br>Is vital capacity assessment linked to indices of respiratory muscle function?